{"id":"https://openalex.org/W1999494306","doi":"https://doi.org/10.2147/dddt.s33110","title":"Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series","display_name":"Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series","publication_year":2012,"publication_date":"2012-06-01","ids":{"openalex":"https://openalex.org/W1999494306","doi":"https://doi.org/10.2147/dddt.s33110","mag":"1999494306","pmid":"https://pubmed.ncbi.nlm.nih.gov/22787386","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3392138"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s33110","doi":"https://doi.org/10.2147/dddt.s33110","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s33110","pdf_url":"https://www.dovepress.com/getfile.php?fileID=12926","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=12926","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112266809","display_name":"Todd Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140312","display_name":"Phoenix Neurological Associates","ror":"https://ror.org/04hk0mm26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140312"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Todd Levine","raw_affiliation_strings":["Phoenix Neurological Associates, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenix Neurological Associates, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210140312"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112266809"],"corresponding_institution_ids":["https://openalex.org/I4210140312"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":3.103,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.90635,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"6","issue":null,"first_page":"133","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dermatomyositis","display_name":"dermatomyositis","score":0.9559999704360962},{"id":"https://openalex.org/keywords/polymyositis","display_name":"polymyositis","score":1.0},{"id":"https://openalex.org/keywords/refractory-myositis","display_name":"refractory myositis","score":0.8999999761581421},{"id":"https://openalex.org/keywords/disease-exacerbation","display_name":"disease exacerbation","score":0.8320000171661377},{"id":"https://openalex.org/keywords/muscle-strength","display_name":"muscle strength","score":0.7599999904632568},{"id":"https://openalex.org/keywords/skin-involvement","display_name":"skin involvement","score":0.7440000176429749},{"id":"https://openalex.org/keywords/treatment-tolerance","display_name":"treatment tolerance","score":0.40700000524520874},{"id":"https://openalex.org/keywords/steroid-sparing-therapy","display_name":"steroid-sparing therapy","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8984882235527039},{"id":"https://openalex.org/C2779387793","wikidata":"https://www.wikidata.org/wiki/Q980926","display_name":"Polymyositis","level":2,"score":0.8845148086547852},{"id":"https://openalex.org/C2778751314","wikidata":"https://www.wikidata.org/wiki/Q681160","display_name":"Dermatomyositis","level":2,"score":0.8148008584976196},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.6872531175613403},{"id":"https://openalex.org/C2780546910","wikidata":"https://www.wikidata.org/wiki/Q185690","display_name":"Adrenocorticotropic hormone","level":3,"score":0.608154833316803},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5960146188735962},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5020411014556885},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4762566089630127},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4214039444923401},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2083037793636322},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003882","descriptor_name":"Dermatomyositis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003882","descriptor_name":"Dermatomyositis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017285","descriptor_name":"Polymyositis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017285","descriptor_name":"Polymyositis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D053580","descriptor_name":"Muscle Strength","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2147/dddt.s33110","doi":"https://doi.org/10.2147/dddt.s33110","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s33110","pdf_url":"https://www.dovepress.com/getfile.php?fileID=12926","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2399434","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3392138","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3392138","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3392138","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmid:22787386","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22787386","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:d3bf08e211494333903bf52bde2af64b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d3bf08e211494333903bf52bde2af64b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol 2012, Iss default, Pp 133-139 (2012)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/10071","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/treating-refractory-dermatomyositis-or-polymyositis-with-adrenocortico-peer-reviewed-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s33110","doi":"https://doi.org/10.2147/dddt.s33110","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s33110","pdf_url":"https://www.dovepress.com/getfile.php?fileID=12926","source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1999494306.pdf","grobid_xml":"https://content.openalex.org/works/W1999494306.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1965014085","https://openalex.org/W1969242938","https://openalex.org/W1972542512","https://openalex.org/W1983302909","https://openalex.org/W2021382556","https://openalex.org/W2040060591","https://openalex.org/W2050765188","https://openalex.org/W2066858700","https://openalex.org/W2072882391","https://openalex.org/W2087124189","https://openalex.org/W2088121511","https://openalex.org/W2097024559","https://openalex.org/W2138232309","https://openalex.org/W2149347708","https://openalex.org/W2164166856"],"related_works":["https://openalex.org/W7100728182","https://openalex.org/W2402352225","https://openalex.org/W2519002891","https://openalex.org/W2406778582","https://openalex.org/W2774777745","https://openalex.org/W4360983727","https://openalex.org/W2410662038","https://openalex.org/W2042132907","https://openalex.org/W2436259342","https://openalex.org/W2217090667"],"abstract_inverted_index":{"BACKGROUND:":[0],"Effective":[1],"and":[2,10,33,51,100,117,128,139,148],"tolerable":[3],"treatment":[4,19,83,126,136],"options":[5],"for":[6,81,145],"patients":[7,27,123],"with":[8,20,47],"dermatomyositis":[9,138],"polymyositis":[11,140],"are":[12],"limited.":[13],"This":[14],"retrospective":[15],"case":[16],"review":[17],"describes":[18],"adrenocorticotropic":[21],"hormone":[22],"(ACTH)":[23],"gel":[24,58,157],"in":[25,108],"five":[26],"who":[28],"experienced":[29],"a":[30,159],"disease":[31],"exacerbation":[32],"either":[34],"failed":[35],"or":[36,70],"were":[37],"unable":[38],"to":[39],"tolerate":[40],"the":[41,76,91,125],"side":[42,131],"effects":[43,132],"of":[44,61,78,84,119,137,155],"previous":[45],"therapy":[46],"steroids,":[48],"intravenous":[49],"immunoglobulins,":[50],"steroid-sparing":[52],"drugs.":[53],"METHODS:":[54],"Patients":[55],"received":[56],"ACTH":[57,146,156],"subcutaneous":[59],"injections":[60],"80":[62],"U":[63],"(1":[64],"mL)":[65],"twice":[66],"weekly":[67,72],"(four":[68],"patients)":[69],"once":[71],"(one":[73],"patient)":[74],"over":[75],"course":[77],"12":[79],"weeks":[80],"short-term":[82],"symptom":[85],"exacerbations.":[86],"Manual":[87],"muscle":[88,113],"testing":[89],"using":[90],"Medical":[92],"Research":[93],"Council":[94],"scale":[95],"was":[96,106],"assessed":[97],"at":[98,101],"baseline":[99],"3":[102],"months.":[103],"RESULTS:":[104],"Improvement":[105],"seen":[107],"all":[109],"patients,":[110],"including":[111],"improved":[112],"strength,":[114],"decreased":[115],"pain,":[116],"resolution":[118],"skin":[120],"involvement.":[121],"All":[122],"tolerated":[124],"well,":[127],"no":[129],"significant":[130],"occurred.":[133],"CONCLUSION:":[134],"The":[135],"is":[141,164],"an":[142],"approved":[143],"use":[144],"gel,":[147],"these":[149],"anecdotal":[150],"reports":[151],"would":[152],"suggest":[153],"consideration":[154],"as":[158],"therapeutic":[160],"option.":[161],"Further":[162],"investigation":[163],"warranted.":[165]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}